Title: Cross-immunity and trained immunity in explaining variable COVID-19 mortality—Guidance for future pandemics
| dc.contributor.author | Sasanka Chakrabarti | |
| dc.contributor.author | Sankha S. Chakrabarti | |
| dc.contributor.author | Upinder Kaur | |
| dc.contributor.author | Bimal K. Agrawal | |
| dc.contributor.author | Upasana Ganguly | |
| dc.contributor.author | Kunlin Jin | |
| dc.date.accessioned | 2026-02-07T10:39:33Z | |
| dc.date.issued | 2021 | |
| dc.description.abstract | [No abstract available] | |
| dc.identifier.doi | 10.1002/jmv.26958 | |
| dc.identifier.issn | 1466615 | |
| dc.identifier.uri | https://doi.org/10.1002/jmv.26958 | |
| dc.identifier.uri | https://dl.bhu.ac.in/bhuir/handle/123456789/37553 | |
| dc.publisher | John Wiley and Sons Inc | |
| dc.subject | coronavirus | |
| dc.subject | cytokines | |
| dc.subject | disease control | |
| dc.subject | immune responses | |
| dc.subject | innate immunity | |
| dc.subject | virus classification | |
| dc.title | Cross-immunity and trained immunity in explaining variable COVID-19 mortality—Guidance for future pandemics | |
| dc.type | Publication | |
| dspace.entity.type | Letter |
